Latha Vairavan, SVP Chief Financial Officer at Arcutis Biotherapeutics, Inc. (ARQT), sold 435 shares at $21.05 ($9K) on 2026-05-11, disclosed to the SEC on 2026-05-13.
Open-market sale of $9k ARQT by SVP Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ARQT | SELL | 2026-02-04 | $34K | — | Filing → |
| ARQT | SELL | 2025-11-05 | $2K | — | Filing → |
| ARQT | SELL | 2025-08-05 | $1K | — | Filing → |